220 results about "Bacterial genes" patented technology

The present invention provides methods and compositions that enable tagging and amplification of targeted RNA molecules. A targeted RNA molecule is any non-polyadenylated RNA molecule including, for example, miRNA, siRNA, rRNA, tRNA, synthetic RNA, or non-polyadenylated mRNA such as mRNA from bacteria. In certain aspects, the invention provides methods and compositions for the genome-wide expression analysis of bacterial genes. Significantly, the methods enable genome-wide expression analysis in circumstances where bacterial numbers were previously too low to purify adequate amounts of RNA for DNA microarray analysis or other applications. Such methods are particularly useful for the study of bacterial gene expression during host-cell infection. The invention also provides kits for tagging and amplifying targeted RNA molecules.

The present invention provides a bacterium having a genome that is genetically engineered to be at least 2 to 14% smaller than the genome of its native parent strain. A bacterium with a smaller genome can produce a commercial product more efficiently. The present invention also provides methods for deleting genes and other DNA sequences from a bacterial genome. The methods provide precise deletions and seldom introduces mutations to the genomic DNA sequences around the deletion sites. Thus, the methods can be used to generate a series of deletions in a bacterium without increasing the possibility of undesired homologous recombination within the genome. In addition, some of the methods provided by the present invention can also be used for replacing a region of a bacterial genome with a desired DNA sequence.

The present invention provides a bacterium having a genome that is genetically engineered to be at least 2 to about 20% smaller than the genome of its native parent strain. A bacterium with a smaller genome can produce a commercial product more efficiently. The present invention also provides methods for deleting genes and other DNA sequences from a bacterial genome. The methods provide precise deletions and seldom introduces mutations to the genomic DNA sequences around the deletion sites. Thus, the methods can be used to generate a series of deletions in a bacterium without increasing the possibility of undesired homologous recombination within the genome. In addition, some of the methods provided by the present invention can also be used for replacing a region of a bacterial genome with a desired DNA sequence.

The present invention relates to nucleic acid molecules which allow the identification of bacteria or groups of bacteria. For detection, the region of the bacterial genome containing the 23 S/5 S rRNA is used as the target sequence for the bacterial detection.

The invention discloses a method for using a machine learning technique for predicting outer membrane protein coded on genomes of germs. The method includes the steps of utilizing a PSI-BLAST algorithm to calculate a location specificity feature vector of the protein, adopting an autocorrelation function for conducting feature conversion, building a classification device based on a supporting vector machine, conducting classification on the outer membrane protein and non-outer membrane protein, receiving a protein sequence input by a user through a local computer program, and predicting whether or not the protein sequence belongs to the outer membrane protein. By means of the method, calculation prediction can be conducted on the protein sequence coded by the whole genome of the germs, thesensitivity is high, the calculation speed is high, and an effective tool is provided for fast identification and screening of inner and outer membrane protein of the genomes of the germs. The methodis an accurate and effective screening method for the outer membrane protein and can be widely applied to identification of the outer membrane protein of new sequencing genomes of germs.

The invention provides gene-inspecting micro-reactor for detecting a bacterial cell wherein flexibility and high sensitivity are secured, low cost by a disposable type is realized, highly accurate detection is possible in a simple structure, and preliminary processing suitable for amplification reaction can be done for specimen efficiently and rapidly.

After lysing a bacterial cell in the specimen by bacteriolysis reagent stored in bacteriolysis reagent storage section 3, and after adsorbing bacterial genes on carriers filled in carrier filling section 4, there is conducted preliminary processing for washing and detecting bacterial genes. Further, there are provided a control means that switches the direction of liquid-feeding for a liquid containing bacterial genes fed to carrier filling section 4, a check valve, amplified reagent storage section 7 and a cooling means such as Pertier element that cools reagent mixing section.

The invention discloses a kit for a magnetic bead method for bacterial genome DNA extraction and an extraction method thereof. The kit includes the following seven components: a buffer solution A, a buffer solution B, a buffer solution C, a magnetic bead suspension solution D, a buffer solution E, a buffer solution F and a buffer solution G. composition of the magnetic bead suspension solution D is 50mg of monodisperse Fe3O4 @ SiO2 AEAPS nanometer magnetic beads in each 200 mmol / L sodium chloride aqueous solution. The extraction method for the kit comprises six steps: thallus re-suspension, cracking, nucleic acid deposition, magnetic bead adsorption, washing and elution. The kit provided by the invention adopts efficient monodisperse nano magnetic beads combined with a unique buffer system, so that the extracted bacterial genome DNA has large fragment, high purity and stable and reliable quality, and can meet the requirements of the follow-up experiments.

The invention belongs to the field of bioengineering, and relates to engineering bacteria constructed by recombining low temperature alpha-amylase gene on an expression vector and converting to an expression host, recombinant enzyme expressed by utilizing the engineering bacteria and application thereof in industry. The invention adopts molecular operating technology, a strain of engineering bacteria EPGS230 is constructed by extracting and stipulating of bacterial genome, amplification of target genes, construction of the expression vector and conversion of recombinant vector, the engineering bacteria is processed by steps of culturing, inducing, centrifuging, ultrasound crushing, ion exchange, affinity chromatography and the like to obtain purified recombinant low temperature alpha-amylase. The inventive preparation technique has the advantages of simple operation, high enzyme activity, and low operative temperature.

The invention belongs to the technical field of bacterial gene engineering of animals, and in particular relates to the construction of a recombinant salmonella choleraesuis strain which does not contain resistance markers and expresses major antigenic loci of porcine transmissible gastroenteritis virus, vaccine preparation and application. In the recombinant salmonella choleraesuis strain C500 (pYA-2SLN) which does not contain the resistance markers and expresses the major antigenic loci of the porcine transmissible gastroenteritis virus, the preservation No. is CCTCC NO: M 209189, and the strain misses asd genes which are necessary for the growth of salmonella choleraesuis and contains plasmid capable of expressing the asd genes, genes of an antigenic locus A, an antigenic locus D and an antigenic locus N321 of the porcine transmissible gastroenteritis virus in the strain. The invention also discloses a method for preparing the salmonella choleraesuis and porcine transmissible gastroenteritis vaccine by utilizing the recombinant strain and application thereof. The prepared recombinant vaccine can stimulate pigs to generate protective immune response for resisting the salmonella choleraesuis and the porcine transmissible gastroenteritis virus, and prevent the infection of the salmonella choleraesuis and the porcine transmissible gastroenteritis virus effectively.

The invention belongs to the technical field of food quality safety detection, and particularly relates to a method in which the processes of fast extraction of co-enrichment and bacterium gene groups and multiple Taqman fluorescence quantitative PCR are used to carry out simultaneous and fast detection on salmonella, staphylococcus aureus and shigella in food and a recombined positive internal reference DNA is designed to monitor PCR reaction so as to guarantee the accuracy of a detected result. The result proves that the method has good specificity for target pathogenic bacteria, the detection limit can reach 101cfu/PCR, and all components of a reaction system do not generate cross interference. Blind sample detection on artificially contaminated foods verifies the practicability of the method. Positive internal reference DNA effectively guarantees the reliability of detection, and avoids the occurrence of false negative results. In conclusion, the invention establishes a multiple fluorescence quantitative PCR method for simultaneous and fast detecting staphylococcus aureus, salmonella and shigella in the food, and provides a new method for high-throughput detection of food origin diseases.

The invention discloses a low-endotoxin escherichia coli prokaryotic expression engineering bacterial mutant strain and a construction method and belongs to the technical field of biological engineering. The low-endotoxin escherichia coli prokaryotic expression engineering bacterial mutant strain can achieve the purpose of reducing the toxicity of lipopolysaccharides by knocking out an msbB gene and a pagP gene for regulating and controlling synthesis of lipoid A fatty acid chains on a bacterial genome with suicide plasmids and a homologous recombination method to reduce the quantity of the lipoid A fatty acid chains and further achieve the purpose of reducing the activity of endotoxin of the strain by expressing pagL and lpxE proteins with exogenous low-copy expression plasmids to simultaneously remove the fatty acid chains and phosphate groups of lipoid A. The lipopolysaccharides produced by the low-endotoxin escherichia coli prokaryotic expression engineering bacterial mutant strain Escherichia coli BL21(DE3)S004 constructed by using the technology, with collection number of CCTCCNO. M2014473 and collection time of October 14, 2014, can stimulate cells to show an obvious effect of reducing the activity of the endotoxin, thereby laying a foundation for subsequent exogenous proteins and targeting medicines using the expression of the engineering bacteria for treatment.

The present invention provides a bacterium having a genome that is genetically engineered to be smaller than the genome of its native parent strain. A bacterium with a smaller genome can produce a commercial product more efficiently. The present invention also provides methods for deleting genes and other DNA sequences from a bacterial genome. The methods provide precise deletions and seldom introduces mutations to the genomic DNA sequences around the deletion sites. Thus, the methods can be used to generate a series of deletions in a bacterium without increasing the possibility of undesired homologous recombination within the genome. In addition, some of the methods provided by the present invention can also be used for replacing a region of a bacterial genome with a desired DNA sequence.

The invention provides a group of peptide nucleic acid-cell penetrating peptide antisense antibacterial sequences taking bacterial gene rpoD as a target. The cell penetrating peptide-mediated antibacterial RNA polymerase sigma 70 factor gene rpoD which is antisense nucleic acid of a specificity target can selectively inhibit the expression of in-vivo ropD genes of Gram-negative bacterium (containing sensitive and multidrug resisting clinical pathogenicity Escherichia coli, salmonellatyphimurium, Klebsiella pneumoniae and pseudomonas aeruginosa) or gram-positive bacterium (containing sensitiveand multidrug resisting staphylococcus aureus) and further inhibit bacteria growth and reproduction, thus having the advantages of good antibacterial effect, low toxicity, good stability and better tolerance. The invention also discloses a chemical preparation method of a peptide nucleic acid-cell penetrating peptide solid phase. The antibacterial peptide synthesized in the invention can be used for preparing multidrug-resistant bacteria infection proofing antisense drugs and has the potency of being developed into a broad-spectrum antisense antibacterial agent which is expressed by efficiently transferred and peculiarly blocked bacterium disease-causing genes.

The invention relates to a method for screening important characteristic genes related to the drug resistance phenotype of bacterial based on a machine learning technology. According to the method, for the antibiotic resistance of the bacterial, on the basis of the BGWAS thought, target bacterial genomes on a public platform or large-sample-size bacterial strain genome data obtained after current collection, sequencing and assembly, and corresponding antibiotic drug susceptibility test results are collected, and correlation analysis between genotypes and drug resistance phenotypes is carried out by using the machine learning method, so that important characteristic genes (non-core drug-resistant genes) related to the drug resistance phenotypes are screened out, weight coefficients of the important characteristic genes are obtained;and finally the reliability of the drug-resistant genes related to drugs is determined by using ROC analysis.

The invention provides a gene chip for detecting an important drug resistant gene of pseudomonas aeruginosa and a kit thereof. The gene chip comprises a solid-phase carrier and an oligonucleotide probe fixed on the solid-phase carrier, wherein the probe comprises a DNA fragment or a complementary DNA fragment thereof selected from carb, tem, imp, oxa group I, oxa group II, aac (6')-Ib, aac (6')-II, aac (3')-I, aac (3')-II, aadB and a bacterium 16S rRNA gene. The gene chip and the detecting kit can achieve the aim of simultaneously detecting the 10 drug resistant genes of the pseudomonas aeruginosa, have the characteristics of high pertinence, high specificity, high sensitivity, high detecting speed, high repeatability, and the like and are suitable for a hospital, a disease preventing control mechanism and other clinical laboratories to carry out drug resistant gene detection and drug resistance monitoring on the pseudomonas aeruginosa.

The invention belongs to the technical field of aquatic organisms and in particular relates to a quick detection method for scallop pathogenic vibrio splendidus. Total DNA (deoxyribonucleic acid) of bacterial genomes in a filtered seawater sample to be detected is taken as a template, fluorescent quantitative PCR (polymerase chain reaction) amplification is carried out by a bacterial 16SrDNA conserved region and a specific primer of a pathogenic vibrio splendidus metalloproteinases gene, and the scallop pathogenic vibrio splendidus in the culture environment is quantitatively analyzed and detected; the detection method comprises the steps of extracting the DNA of the bacterial genomes and carrying out fluorescent quantitative PCR detection. The method has the advantages that the quickness is achieved, the specificity is good, the bacterial density detection range is wide, and a quantitative result can be close to a real situation.

The invention belongs to animal bacterium gene engineering field, relates to form stem of Actinobacillus pleuropneumoniae APP-1-mut01 digene deletion mutants without fastness label, preparing vaccine and application thereof. The invention gets a stem of Actinobacillus pleuropneumoniae APP-1-mut01 (storing number is CCTCC NO; M207005). The stem absents two main toxin gene activity factors apxIC and apxIIC of Actinobacillus pleuropneumoniae APP-1-mut01, produces toxin albumen ApxIA and ApxIIA without toxin, but these two toxin albumen also have immunity originality. The invention also discloses producing vaccine of Actinobacillus pleuropneumoniae APP-1-mut01 using the digene deletion mutants stem and application thereof. The digene deletion vaccine can irritate pig generate protective immunity reaction to resist isogeny and nonhomology serum wild strain of actinobacillus pleuropneumoniae to prevent infection thereof.

The invention discloses a method for combined treatment of wastewater of a phenol-containing gas by an ozone flocculant. The method is characterized by comprising the following steps of: (1) oxidization treatment, namely carrying out oxidization treatment on synthetic natural gas (SNG) waste water by using ozone; (2) carrying out primary intermediate reservoir treatment; (3) carrying out flocculation dosing treatment, and feeding a compound agent containing aluminum; (4) carrying out precipitation reaction treatment; (5) carrying out secondary intermediate reservoir treatment; and (6) processing by a biological response processor, namely feeding the water from a secondary intermediate reservoir to a biological reaction tank, wherein the standing time of the biological response processor is 4-20 hours; processed water is recycled; biological sludge is domesticated by bottom mud of a sewage pool at scene; bacteria Bacuillus sp.JY01 capable of degrading phenol is added; the gene registration number is EU798946.